Intratympanic injection with dexamethasone for sudden sensorineural hearing loss

Intratympanic injection with dexamethasone for sudden sensorineural hearing loss - IT-DEX for SNHL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005953

Enrollment

Registered

2011-07-11

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sudden sensorineural hearing loss

Interventions

Intratympanic injection with dexamethasone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: sudden sensorineural hearing loss and not improve within 14 days after initial treatment

Exclusion criteria

Exclusion criteria: acute low tone hearing loss

Design outcomes

Primary

Measure	Time frame
pure tone audiogram and DPOAE	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026